TVB2640, a FASN inhibitor, has been observed to have a significant inhibitory effect on tumor growth in cancer cell lines and xenograft models, but due to its pharmacological nature, its clinical transformation and application are limited (244). The gene discussed is FASN; the disease is neoplasm.